Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for treating Attention-Deficit/Hyperactivity Disorder in youngsters and grown-ups . It's functions as a prodrug, meaning it’s inactive until metabolized by the body, providing dextroamphetamine gradually over an exten